“…Despite showing a strong familial aggregation [8][9][10], attempts to identify genetic factors associated with FM (primarily through polymorphism 2 Nursing Research and Practice association studies) have yielded inconsistent results, with some investigators showing associations between FM and specific genes (including, but not limited to, genes for catechol-O-methyltransferase [11][12][13], serotonin-2A receptor [14,15], serotonin transporter gene regulatory region [16,17], dopamine D4 receptor [18], -2 adrenergic receptor [19], gamma-aminobutyric acid receptor subunit beta-3, trace amine-associated receptor 1, interferon-induced guanylatebinding protein 1, regulator of G protein signaling 4, cannabinoid receptor type 1, and glutamate receptor 4 [20]), while others failed to identify a relationship [21][22][23][24][25]. Since a consistent, straightforward association with a gene (s) has not yet been forthcoming, scientists have suggested that the familial influence on FM may more likely reflect a genetic susceptibility to environmental events [21,26,27]. For example, Klengel and Binder [28] identified differential methylation for a glucocorticoid response element (the FKBP5 gene) that resulted from the presence of both an "at-risk" allele (polymorphism) and the occurrence of childhood trauma in subjects they studied who had posttraumatic stress disorder.…”